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Abstract
A general methodology is described to validate a 3D imaging modality with respect to 2D 
digital subtracted angiography (DSA) for brain AVMs (BAVM) delineation. It relies on the 
assessment of the statistical compatibility of the radiosurgical target delineated in 3D with 
its delineations in 2D. This methodology is demonstrated through a preliminary evaluation 
of rotational 3D angiography (3DRA). Generally speaking, BAVM delineation cannot be 
performed on 3DRA alone. However, in our study, 3DRA showed similar performances to 
DSA for  rather easy cases,  and even better  for  3  patients.  Conversely,  3 problematic 
cases are identified and discussed.
Key words:  Angiography,  Brain  Arteriovenous Malformation,  Radiosurgery,  Validation, 
Principal Component Analysis
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1 Introduction
Brain  arteriovenous malformations  (BAVMs)  are  complex  pial  or  subpial  arteriovenous 
shunts which can pose therapeutic  problems. The major threat  from a BAVM is  brain 
hemorrhage. The natural course is still not very well known, but it seems that the risk of 
hemorrhage  increases  with  BAVM  volume,  patient  age,  central  location  and  prior 
hemorrhage. Most patients with BAVM are therefore subjected to treatment with surgery, 
embolization or radiosurgery (RS), unless the risk posed by the remedy itself is considered 
to be unacceptable. 
RS is unique in that the outcome can be predicted from mathematical models [1]. The 
chances for  BAVM obliteration after  RS depend on the dose of  radiation given to the 
periphery  of  the  target  [2,3].  Adverse  radiation  effects  (ARE),  in  the  worst  case 
radionecrosis, constitute the main potential drawback. The risk for ARE depends on the 
location  of  the  lesion  and  total  amount  of  energy  delivered,  i.e.  BAVM  volume  and 
radiation dose [2].  There is also a risk of hemorrhage during the latency period before 
obliteration, a risk that varies according to treatment parameters, AVM volume and patient 
age [4]. 
RS  may  be  carried  out  with  proton  beams,  the  Gamma  Knife  (Elekta,  Stockholm, 
Sweden) or a linear accelerator. In the latter case multileaf collimators are required to 
irradiate complex-shaped targets, such as BAVMs. The definition of the target volume is 
an essential  stage of  the treatment  regardless of  equipment.  The totality  of  the nidus 
(which is the active part of the AVM) and as little as possible of the surrounding brain 
tissue should be included within the prescription isodose, in order to limit the risks of ARE. 
Indeed, the reasons for failed AVM obliteration are various but partial volume irradiation is 
put forward as a major cause by many authors [5-9]. 
Whereas in the case of tumours this volume is obtained from computed tomography 
(CT) or magnetic resonance (MRI) imaging, digital subtracted angiography (DSA) is still 
the gold standard for determining the target volume in the case of BAVMs [9-11]. The AVM 
nidus consists of a complex tangle of abnormal vessels with arteriovenous shunting. Only 
the detailed analysis of different times of opacification of an angiographic series allows us 
to precisely determine the contours of this nidus and to differentiate it from the related 
arteries and the draining veins. The spatial and especially temporal resolutions of DSA are 
better than those of CT and MRI and thus allow for a more precise target definition. 
Using DSA, the target volume is reconstructed from the contours drawn independently 
on two or more perpendicular or oblique views (see figure 1), in stereotactic conditions. 
Due to the nature of DSA, where the image is projected onto two dimensions, the three-
dimensional (3D) target volume cannot be reconstructed with complete accuracy [12]. This 
limitation of DSA has long been acknowledged, especially in the case of complexly shaped 
BAVMs [13]. Methods have been developed that aim at better estimating the nidus shape 
from  two  perpendicular  angiographic  projections  [14,15].  These  techniques  basically 
assume the target presents an ellipse shape in every axial cut plane. Though they were 
shown  to  improve  the  accuracy  of  the  target  volume  computation  (in  the  sense  of 
containment), their ability to provide an accurate target shape has not been demonstrated. 
The aim of this paper is twofold: 
i. In section 2.1, we propose a method to validate AVM targets determined from a 
3D imaging modality. 
ii. In section 2.2, we describe a clinical pilot study investigating the use of (“3D”) 
rotational angiography (3DRA) to delineate the AVM radiosurgical target.
A preliminary account of these findings has been presented in [16].
2 Material and methods
2.1 Statistical methods
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2.1.1 Basic assumptions and outline of the method
The  general  method  for  validating  a  given  3D modality  in  the  framework  of  RS was 
designed assuming the following experimental conditions. A set of patients was involved in 
the experiment. For each patient, a set of DSA views and one 3D image (e.g. MRI, CT or 
3DRA) were available. The DSA views were corrected for geometric distorsions and the 
3D image was spatially registered with the DSA views. 
Two segmentation processes were to be compared: 
i. A test process, applied on the 3D images. This process could be either manual, 
with a new delineation protocol, or automatic, thanks to a new image processing 
algorithm. 
ii. A reference process, applied on the 2D images. In our case, this process was 
the manual contouring of the AVMs in the DSA views by experts. 
Each process generates 3D targets. Consequently, for each patient, a set of 3D targets 
was to be compared to a set of reference 3D targets by experts. 
For each patient, all the test 3D targets and all the expert 3D targets were reprojected 
onto all DSA views. A set of test 2D curves together with a set of expert 2D curves were 
thus provided for each patient and each DSA view. 
The general strategy of our method consisted in first designing a statistical test for a 
given test  2D curve  to  be  accepted as valid,  given a reference curve distribution.  An 
acceptance rate was then computed for the test curves and compared to an expected 
acceptance rate estimated from the reference data. 
2.1.2 Building a statistical shape model
A statistical shape model was built as introduced by Cootes [17]. This mathematical tool 
makes it possible to learn what variations in shapes are plausible, based on a set of expert 
reference curves. One model was built per DSA view, by analyzing shape variations over 
the training set of M  2D expert curves {C i }1≤i≤M  
Cootes’ method [17] requires that all curves are resampled on the same number N  of 
points so that they are set into a one-to-one correspondence. This matching step must be 
done  carefully  for  the  shape  model  to  make  sense  [18].  For  our  particular  clinical 
application, dense point-to-point correspondences between curves were established using 
a semi-interactive interface (see figure 2). Segments were drawn by the user and linear 
interpolation was performed between these cuts. In practice, cuts were chosen so as to 
delimit  areas  where  the  expert  curves  were  in  good  agreement  from  areas  which 
presented high variability. 
Each  curve  C  can  therefore  be  represented  as  a  2N  dimensional  vector, 
concatenating the x  and y  coordinates of the N  sample points. The average curve is 
defined as the average vector: 
C=
1
M ∑i
C i (1)
with the covariance of the curve data: 
Σ=
1
M ∑i
C i−C  C i−C 
t
(2)
Still  following  Cootes  [17],  a  linear  eigen-model  was  built  by  applying  principal 
component  analysis  (PCA).  The  eigenvectors  of  Σ  corresponding  to  the  t  largest 
eigenvalues represent the  t  principal modes of variation. Let  P  be the  2N×t  matrix 
gathering these eigenvectors. A particular curve C  is then approximated by: 
C '≈CPb (3)
where b=P t C− ̄C  . The squared error of this approximation is: 
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r 2 C =∥C−C '∥2=C−C 
t
C−C −b t b (4)
2.1.3 Acceptance test for one curve
Once the model had been built, an acceptance test had to be designed to decide how a 
test curve matched the model. A first measure of the quality of fit is classically deduced 
from the PCA: 
Fm C =∑
k=1
t bk
2
λ k
(5)
where λ k  is the k -th largest eigenvalue in the PCA and bk  the k -th component of b . 
This criterion compares, for each mode k , the observed variation bk
2
 on curve C  to the 
expected  variation  λ k .  This  value  only  measures  the  distance  by  which  the  shape 
deviates from the mean along the modes of the model. It does not consider the distance 
r 2C   of  the  test  curve  from its  linear  approximation  (see equation  (4)).  Ideally,  this 
distance should be small, meaning that the linear model given in equation (3) is able to 
closely model any curve bound to be an acceptable AVM contour. 
In order to define what “small” means, an expected residual distance was evaluated for 
each linear model using leave-one-out experiments: for each expert curve C i , a reduced 
PCA model was built from all the expert curves except C i . The residual of this reduced 
PCA is denoted ri
2
. The expected residual was given by: 
r e
2
=
1
M ∑i=1
M
r i
2 C i  (6)
Besides, the residual observed on a new curve C  in this experiment was: 
r o
2
=
1
M ∑i=1
M
r i
2 C  (7)
The compatibility of the new curve C  was given by: 
F r C =
r o
2
r e
2
=
∑i=1
M
r i
2 C 
∑i=1
M
r i
2 C i 
(8)
The entire measure of fit was then defined as the sum 
F C =F m C Fr C  (9)
2.1.4 Study of the distribution of F
F  theoretically obeys a chi-square law. The actual distribution could be estimated through 
leave-one-out experiments on the expert curves as follows. For each expert curve C i , a 
reduced set of reference curves was considered, gathering all expert curves but  C i . A 
measure of fit F i  (see equation (9)) was then defined as above for the curve C i , based 
on this reduced set. Testing of all expert curves in all DSA views provided an estimate of 
what the actual distribution of the fit measure was amongst experts. 
2.1.5 Global acceptance rate for all test curves
Thanks to the above chi-square test, an accept/reject decision could be taken for each 
DSA view. Consideration of all the DSA views led to a percentage of acceptance of test 
curves.  Unless  this  percentage  was  convincingly  high,  the  question  arose  of  the 
significance of the computed acceptance rate. 
An expected acceptance rate could be estimated through leave-one-out experiments on 
the expert curves as above. An accept/reject decision was taken for each expert curve C i
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,  based  on  F i .  Consideration  of  all  expert  curves  provided  an  estimate  of  what  the 
“natural” acceptance rate was amongst experts, setting a reference for the acceptance 
rate of new contours. 
2.2 Application to 3DRA
The method formally described above was applied to a preliminary investigation: 3DRA 
was tested to delineate complex BAVM target shapes. 
2.2.1 Clinical material
Eleven patients with BAVM were consecutively treated using embolization and RS at the 
University Hospital of Nancy (France) between June 2001 and January 2002. According to 
the complexity of the AVM shape, between 2 to 5 (2D) DSA views were considered for 
delineation  (antero-posterior,  lateral  and  oblique  views).  Overall,  37  DSA series  were 
available for  this study. In addition,  one 3DRA volume was available for  each patient. 
These images were acquired in  stereotactic  conditions,  allowing for  DSA/3DRA image 
registration. 
2.2.2 Reference data
Three  experts  in  interventional  neuroradiology  from  the  University  Hospital  of  Nancy 
(France) and Karolinska Institute (Stockholm, Sweden) were involved in this study. They 
manually delineated twice at a one month interval the AVMs in the 37 DSA images. The 
delineation was done with the software used in clinical practice (Advantage Windows, GE 
Healthcare). The full DSA series was available so that hemodynamics could be leveraged 
to analyze the angioarchitecture (feeding arteries, nidus and draining veins) and better 
assess the actual nidus contours. Each time, the AVM nidus was reconstructed, based on 
the  expert  delineation  in  all  the  available  views.  This  reference  3D  shape  was  then 
reprojected on each available view. Thus, 6 contours of reference were available on each 
DSA image (see figure 3). 
2.2.3 Test data
For each patient Maximum Intensity Projection (MIP) images of the 3DRA were generated 
with the same viewing parameters as used for the acquisition of DSA images (see figure 
4). The same three experts were asked to delineate the AVMs in these MIP views, using 
the  same delineation  software  as  for  DSA images.  In  the  absence  of  hemodynamics 
information in 3DRA, the 3DRA volume was available to display using volume rendering 
software (Volume Viewer, GE Healthcare), in a view to analyze the angioarchitecture using 
full  3D information. Again, each AVM nidus was reconstructed using cones intersection 
and this new 3D shape reprojected onto the available views. These contours were then 
tested using the statistical model built from the six expert delineations. 
2.2.4 AVM classification
Each  expert  was  asked  to  label  each  AVM  with  A  or  B  according  to  the  difficulty 
encountered when delineating the nidus on DSA series: label A was given when no major 
difficulty was faced, whereas label B was affixed when the delineation required a very 
thorough analysis with difficult choices to make. Along with a B labelling, the experts were 
asked to list their reasons underlying their choice. Figure 4 shows an example of an A-
labelled AVM, and a B-labelled AVM can be seen in figure 5. 
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3 Results
3.1 Test parameters
For each DSA view, a shape model was built based on the 6 reference contours. The 
number  t  of modes considered to compute  Fm  was chosen to represent 95% of the 
variation in the reference contours. 
In order to study the actual distribution for F , the experiment described in section 2.1.4 
was performed. The training set enabled us to test 222 expert curves ( 3×2  expert curves 
on 37 DSA series). Each measure of fit was associated to a number of modes for the 
underlying model: 163 models had 3 modes, 53 had 2 modes, and the last 6 models had 4 
modes. The distribution of the  F i ’s based on 3 modes was therefore studied with the 
hypothesis that either 3 or 4 degrees of freedom should be considered for the actual chi-
square distribution (number of modes vs number of summed terms in equation (9)). As 
shown in figure 6, the latter hypothesis is the one that was eventually retained. 
Therefore,  t+ 1  degrees of  freedom and a  p-value of  0.05 were considered in  the 
experiment. 
3.2 AVM classification
Each  AVM was  classified within  type  A or  B,  based on the  consensus  among the  3 
experts: 5 AVMs were labelled as A (17 DSA series) and 6 as B (20 DSA series). Most 
noted  difficulties  were  the  lack  of  clarity  of  the  nidus  due  to  diffuse  compartments, 
neoangiogenesis or previous embolization and the lack of a conspicuous nidus contour 
because vessels are superimposed. 
3.3 Global acceptance rate
Results about the acceptance rates are summarized in table 1. 
DSA acceptance rates call for two comments. First, in the case where the fit measure 
F  would faithfully follow a chi-square distribution, a p-value of 0.05 would let us expect a 
reference acceptance rate of about 95%. It is not the case here, as is also apparent in 
figure 6: the tail of the observed distribution shows outliers. Second, the better acceptance 
rate for  label  A AVMs than for label  B AVMs is consistent  with the estimation by the 
experts of an easier, and therefore less variable, delineation of label A AVMs. 
3DRA acceptance rates show that  global  AVM delineation cannot  be performed on 
3DRA alone (table 1, column for labels A&B) but should be considered as a complement 
to DSA  for rather easy cases (table 1, column for A-labelled AVMs). 
3.4 Per patient acceptance rate
A  patient  by  patient  analysis  (table  2)  reveals  a  more  interesting  situation.  DSA 
acceptance rates demonstrate that our chi-square test enabled us to correctly label the 
delineation difficulty for all patients but A3 and B4: A-labelled AVMs correspond to a DSA 
acceptance rate above 85%. 
The situation for 3DRA is somewhat different. 3DRA acceptance rates are similar to the 
reference DSA rate for 5/11 patients (A2, A3, A4, B2 and B3). The 3DRA rate is even 
higher than the DSA rate for 3 patients (A4, B2 and B3). In contrast, this rate is drastically 
low for 3 patients (B1, B5 and B6). These cases will be discussed in the next section. 
4 Discussion
4.1 DSA as a reference
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DSA still  remains the benchmark imaging modality to delineate BAVM for RS. Besides 
having  unequalled  spatial  resolution,  DSA is  the  only  modality  that  provides  sufficient 
temporal resolution to study the hemodynamics. This point is key in analyzing BAVM: the 
nidus  must  be  delineated  at  an  early  phase  of  the  arterial  time,  when  the  nidus  is 
completely opacified, just at the beginning of the venous drainage. Capturing this instant in 
time requires an image acquisition rate of at least 2 images per second. If taken too early, 
the DSA image might not display the whole nidus. If taken too late, superimposed venous 
drainage would degrade the nidus visibility. 
However, it has long been acknowledged that DSA has severe limitations. Many views 
are required to delineate a 3D target but it is often difficult to find enough views where the 
nidus is clearly visible. Superimposed images of adjacent vessels, uncertain contours due 
to  neoangiogenesis  or  previous  embolization,  or  inhomogeneous  opacification  are 
common. As a consequence, the epipolar consistency of the contours between views is a 
condition that is seldom fulfilled and is not easy to control [19], in particular when oblique 
views are added (see figure 7). 
Further, even when many views are available, the methods for reconstructing AVM from 
contours drawn in DSA are unable to deal with all types of concavities in the shape [9] 
(see figure 1). More generally speaking, an infinite number of 3D shapes fit a given set of 
any number of projections. For example, in figure 1 (right), both the bold line convex shape 
and the concave shape have the exact same reprojection contours in all 5 views. 
4.2 Interest of 3D
3D imaging thus seems essential for the accurate determination of BAVM target shape. 
CT and/or MR alone do not seem to be reliable enough to differentiate the AVM nidus from 
the other adjacent vascular structures even when injected volume acquisitions are used 
[9,20]. Nevertheless these 3D imaging modalities are used by many teams to refine the 
initial approximate volume reconstructed from DSA [5,9,21]. 
Three-dimensional  rotational  angiography (3DRA)  is  a  novel  imaging  technique [22] 
offering a selective vascular 3D analysis with a high spatial resolution (0.25 mm). 3DRA 
provides very useful  3D information that has been clinically validated for endovascular 
treatment of intracranial aneurysms [23]. It can also be used for a better understanding of 
the nidus shape as shown in a preliminary study [8] but this technique has not yet been 
validated for use on AVM. 
All 3D modalities lack the temporal resolution that DSA provides. As a result, fast flow 
compartments or diffuse parts of the nidus might not be visible in the 3D image. On the 
other hand, vessels and nidus never become superimposed in 3D. In the framework of 
BAVM radiosurgery, validating a 3D modality comes down to validating the target shape 
that can be determined from the 3D image alone. The clinical outcome must definitely be 
investigated. However, such a study will take a long time since the incidence of BAVM is 
very low and the variability of cases is high [24,25]. In addition, only underestimation of 
target volume can be proven by lack of treatment effect. Overestimation of target volume 
may actually show up as an apparent increase in treatment efficacy, since the likelihood of 
obliteration will increase with the higher dose of radiation to the periphery of the BAVM. 
The concomitant increased risk for undue radiation effects will not be appreciated since 
the target definition was a priori correct. 
A  first  validation  step  can  be  taken  by  comparing  the  target  delineated  in  the  3D 
modality to the target reconstructed from reference standard DSA. Various criteria were 
proposed to  that  aim. The volume (expressed in  cc) [14,15,20,26],  the position of  the 
center of  mass [9,20,26-28],  or  the largest or mean dimension [8,20] of  the target will 
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provide valuable information, but cannot ensure that it will be noticed when reconstructed 
targets have the wrong shape. More complex criteria were proposed to better take into 
account the target shape: ratio of the intersecting volume over the encompassing volume 
[26,28],  overlapping  contours  [9],  largest  dimensions  in  several  directions  [27].  More 
recently, surface to surface distance computation, associated to local analysis along the 
target surface was proposed for lung cancer delineation [29]. 
Such studies failed to provide a definite answer about the actual use of the investigated 
3D modality for AVM radiosurgery. Practical and clinical arguments were called upon in 
the end for recommending it as a complement to DSA. Whereas the above criteria tend to 
a  better  analysis  of  the  target  shape,  the  characterization  of  the  correct  shapes  they 
provide is not local enough to discriminate wrong shapes. Furthermore, the above studies 
faced a fundamental  difficulty  in taking the target reconstructed in  3D from DSA as a 
reference:  though  great  care  was  taken  in  using  complex  and  state-of-the-art 
reconstruction methods, such a reference should still be acknowledged as possibly false 
and subject to high intra- and inter-observer variability [30]. 
 
4.3 Paper contributions
4.3.1 A new validation methodology
Evaluating a segmentation with respect to expert delineations has long been recognized 
as a difficult problem [31,32]. Various methods have been proposed for comparing given 
segmentation  with  those of  a  group of  experts.  The simplest  approaches,  in  2D,  use 
metrics on curve distances [33]. Other techniques compute the agreement of the curve 
under consideration with the joint agreement of the experts, provided that a convenient 
metric on curves is available [31]. More sophisticated methods try to define a statistical 
model of the shape [17] or a probabilistic framework allowing the definition of the true 
segmentation and a measure of performance to be associated to each segmentation [32]. 
In our application, manual delineations suffer from observer bias and large inter- and 
intra-observer variability (figure 5, left): areas where the consensus is good alternate with 
areas where the expert  delineations are highly variable,  preventing us from defining a 
reliable  metric  between  curves  and  from  using  the  methods  described  in  [31].  The 
STAPLE methodology  [32]  aims  at  estimating  the  true  segmentation  from the  expert 
delineations.  This  methodology  is  well  suited  to  region  segmentation  but  needs  to 
incorporate  a  model  describing  spatially  correlated  structures.  Such  assumptions  are 
clearly  not  fulfilled  in  our  case:  due  to  large  image  inhomogeneities  in  the  AVM 
appearance,  AVM detection  cannot  be  formulated  as  a  region  segmentation  problem. 
Moreover, due to the large variability of the AVM shape, it is impossible to build a model 
that provides prior information on the expected shape. 
The first contribution of this paper is a methodology for validating a 3D imaging modality 
for BAVM delineation. The strong points of this methodology are the following. 
The argument that the comparison should be made in 2D whenever DSA is considered 
as a reference. Indeed, 3D targets reconstructed from delineations in DSA are known not 
to be trustworthy everywhere: only the projections of these 3D shapes back onto the DSA 
views (i.e. 2D curves) can actually be considered as reference data. As a consequence, 
making the comparison in 3D is not valid. 
The contour curves to serve as reference should be consistent in 3D. It occurred that 
some medical experts chose to draw a larger contour for the nidus in areas where the 
image was not clear, thus making use of the fact that a different DSA view could bring a 
correction to the current view. As a consequence, the original DSA contours were not to be 
considered as reference data but rather the reprojection of the reconstructed 3D target. 
Figure 3 demonstrates how this reduced the variability in the delineation. 
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The design of a statistical acceptance test for a given test curve, based on a PCA of the 
expert curves. This statistical test relies on the computation of a measure of fit F  as the 
sum of  two terms (see equation (9)).  The first  term  Fm  controls  variations along the 
modes  of  the  model,  that  is,  along  the  parts  of  the  nidus  contour  where  the  experts 
disagree, binding the distance from the mean curve to remain within the observed limits. 
The second term Fr  penalizes any variation in ways not seen in the training set, that is, 
where the experts agree [17]. As a result, this test makes it possible to locally adapt the 
decision of acceptance/rejection.Theoretically,  F  should follow a chi-square law with  t  
degrees of freedom. In practice, the global chi-square shape is usually a valid hypothesis 
but the number of degrees of freedom must be adapted to the training set [17]. Leave-one-
out experiments showed that t+ 1  degrees of freedom should be considered for the chi-
square distribution modeling F  in the case of BAVM contours. 
In this paper, the clinical experiment focused on 3DRA but this methodology can be 
applied to any 3D modality. 
4.3.2 Preliminary investigation of 3DRA
The second contribution is clinical. A database of AVM cases has been constructed and 
the  delineation  process  has been  carefully  studied.  Our  experiments  showed that  the 
variability between experts can be very large. Physicians should be more aware of the 
importance  of  this  variability  and  protocols  for  delineation  should  be  standardized. 
Moreover,  computed  acceptance  rates  showed  that  BAVM  delineation  could  not  be 
performed on 3DRA alone. However, this modality is promising and should be considered 
as a complement to DSA. 
The per-patient analysis (see table 2) gave example cases of  this complementarity. 
Cases B2 and B3 were considered as difficult ones, but present with a better acceptance 
rate  using  3DRA  than  DSA.  These  were  AVMs  with  a  rather  large  nidus,  strongly 
remodeled by previous embolization but with limited venous drainage. Conversely, 3DRA 
was unable to faithfully depict the nidus of 3 B-labelled patients (B1, B5 and B6). The 
corresponding  AVMs  had  in  common  to  present  with  an  important  and  fast  venous 
drainage that superimposed onto the nidus in DSA views, and was reconstructed in 3DRA 
volumes. In other words, 3DRA is a better aid to understanding complex 3D shapes, such 
as  remodeled  nidii,  but  lacks  the  temporal  resolution  of  DSA,  which  is  necessary  to 
distinguish the draining veins from the nidus. 
However,  this  last  point  highlights  one limitation of  this  study:  the  views chosen to 
delineate the nidus in 3DRA were the same as in DSA since our aim was to demonstrate 
the potential of our methodology. In order to fully demonstrate the capacity of 3DRA to 
display the nidus with all the required conspicuity, and in particular to distinguish the nidus 
from the draining veins, the experts should be allowed to take better advantage of 3DRA 
by choosing carefully adapted views, even, and especially, views that are not allowed by 
DSA, such as axial (or top) views. We believe that the third spatial dimension of 3DRA can 
compensate for its lack of temporal resolution. Moreover, the contrast medium injection 
protocol for 3DRA should be improved for cases with a large draining vein. 
4.4 Future works
Several improvements and extensions can be made to our approach. The database must 
be  enriched,  especially  with  label  A malformations.  It  would  also be  convenient  if  the 
construction  of  the  statistical  model  of  the  shape  could  be  facilitated.  Short-term 
improvements  consist  in  allowing curves instead of  segments for  cuts  in  our  software 
interface  used  to  match  contours  (see  dark  segments  on  figure  2).  More  robust  and 
automated matching could be used but it either requires to have similar curves [34] or to 
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define expected properties of the dense curve matching [18]. None of these conditions are 
met in our case.
Multimodality  methods  are  under  investigation  in  order  to  improve  the  current 
delineation process.  One research direction is  to  use 3DRA to build  virtual  2D views. 
Hence, the physician could potentially use an arbitrary number of views to delineate the 
AVM without further dose exposure to the patient. The accuracy of the target shape will be 
improved as the precision of the shape recovered with cone intersections is tightly related 
to the number of views that can be considered. 
Outlining a 3D shape is classically performed by manually drawing contours in 2D cut-
planes through the pathology. With AVMs, this is a very difficult task (see figure 8). In this 
paper, the 3DRA target volume was built by cone intersection from contours drawn in MIP 
views. Concavities in the target cannot be fully recovered with this method. Among other 
advantages, 3D modalities, and in particular 3DRA, should make it easier to segment the 
AVM nidus than when DSA is used. A further step to improve the target delineation is to 
use  quasi-automated  algorithms  to  reduce  variability.  We  are  currently  working  on 
evaluating active surfaces to that aim. 
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Figures and tables
Fig. 1:  AVM reconstruction using conventional angiography. Left: setup with 2 orthogonal 
views. Right: concavities cannot be recovered even with many views.
Fig. 2: Semi-interactive interface to match curves: the segments in black were indicated by 
the user to define homologous sections of curves; the segments in gray show the point-to-
point correspondence established between two curves within the set.
Fig. 3:  (From left to right) 1) The set of 6 original expert delineations. 2) reconstructed 
surface  in  the  same  orientation  as  the  DSA  view  3)  The  new  database  using  the 
reprojection of the 3D shape recovered from expert delineations for the same view. 4) 
Reprojection of the recovered 3D shape on a reference image in semi-transparent light-
gray along with the expert delineation. Data for patient A2 in table 2. 
Fig. 4: Example of A-labelled AVM. From left to right in AP orientation: DSA image; DSA 
image  with  all  original  expert  delineations;  3DRA  MIP  image  with  all  original  expert 
delineations; 3DRA MIP. Little vessel superimposition and a limited venous drainage for a 
nidus  with  moderate  flow speed.  A  high  quality  3DRA reconstruction  with  no  artefact 
displays an apparently even more conspicuous nidus. Data for patient A2 in table 2.
Fig. 5: Example of B-labelled AVM. From left to right in AP orientation: DSA image; DSA 
image  with  all  original  expert  delineations;  3DRA  MIP  image  with  all  original  expert 
delineations; 3DRA MIP. This large nidus appears unclear on most of its contour due to 
artery  superimposition  and  large  previously  embolized  areas  (right  and  bottom).  The 
venous drainage hampers the analysis of the upper part of the nidus in 3DRA. Experts 
excluded this part in 3DRA whereas it was always included in DSA. Moreover, the 3D 
reconstruction  of  the  nidus  presents  with  a  poor  quality  especially  in  the  previously 
embolized areas. Data for patient B3 in table 2.
Fig. 6: Distribution of the measures of fit for the expert curves in DSA views corresponding 
to models with 3 modes: the data histogram fits the chi-square distribution with 4 degrees 
of freedom. 
Fig.  7:  Contour  consistency.  Top  row:  DSA  views  with  one  original  expert  manual 
delineation (curve in white) and the reconstructed target (semi-transparent light grey) in 
antero-posterior,  lateral  and oblique orientations  (from left  to  right).  The reconstructed 
target in AP orientation is shown on the right. Second row: the DSA views with no graphics 
superimposed for reference. The reconstructed target in lateral orientation is shown on the 
right.  Even though every contour seems correct independently on each DSA view, the 
large difference in  the AP view between the initial  contour  and the reprojected  target 
demonstrates their inconsistency in 3D. Data for patient A2 in table 2.
Fig.  8:  Difficulties  encountered  when  reconstructing  an  AVM  3D  shape  from  manual 
outlines in a stack of axial cut planes. (Left) A 3DRA axial plane through an AVM: the 
different vascular structures cannot be easily distinguished. (Middle) Two consecutive axial 
planes  in  T1  Gd-enhanced  MRI  together  with  the  manually  drawn  AVM  (Right) 
Reconstruction of an AVM by stacking up these manual outlines: the smoothness of the 
3D shape is not ensured in the longitudinal direction. 
Table 1
global acceptance rate acceptance for acceptance for 
(labels A & B) label A AVMs label B AVMs 
3DRA 69% 82% 58% 
DSA 84% 87% 81% 
Table 1: Acceptance rate of 3DRA contours (second line) compared to the acceptance 
rate  of  DSA  (third  line)  computed  as  explained  in  section  2.1.5.  DSA  rates  were 
established on 222 contours and 3DRA rates on 111 contours.
Table 2
Patient A1 A2 A3 A4 A5 B1 B2 B3 B4 B5 B6 
Nb of DSA series 3 3 4 3 4 4 3 4 3 3 3 
DSA acceptance rate 89% 94% 79% 89% 88% 83% 72% 79% 89% 83% 83% 
3DRA acceptance rate 78% 89% 75% 100% 75% 17% 89% 100% 67% 33% 44% 
Table 2: Per patient acceptance rates: DSA rates are computed on 18 or 24 curves (6 
curves per DSA series) and 3DRA rates on 9 or 12 curves (3 curves per 3DRA MIP view). 
The DSA data consisted of a total of 37 series; Patients A1 to A5 are A-labelled and B1 to 
B6 are B-labelled. Note the AP data for patient A2 are presented in figure 4 and AP data 
for patient B1 are presented in figure 5.
